4 ANTI-VEGF/DLL4 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다. Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis,...

Full description

Saved in:
Bibliographic Details
Main Authors HAASCH DEANNA L, LAPPE SUSAN E, CHARI RAVI, LI YINGCHUN, AMBROSI DOMINIC J, GU JIJIE, NAUMOVSKI LOUIE, GUPTA SUPRIYA, CAO XIANHUA, HICKSON JONATHAN A, ZAMIRI CAMELLIA
Format Patent
LanguageEnglish
Korean
Published 19.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다. Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases diseases characterized by aberrant DLL4 and/or VEGF expression or activity.
AbstractList 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다. Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases diseases characterized by aberrant DLL4 and/or VEGF expression or activity.
Author HICKSON JONATHAN A
GU JIJIE
HAASCH DEANNA L
CHARI RAVI
GUPTA SUPRIYA
CAO XIANHUA
LAPPE SUSAN E
AMBROSI DOMINIC J
ZAMIRI CAMELLIA
NAUMOVSKI LOUIE
LI YINGCHUN
Author_xml – fullname: HAASCH DEANNA L
– fullname: LAPPE SUSAN E
– fullname: CHARI RAVI
– fullname: LI YINGCHUN
– fullname: AMBROSI DOMINIC J
– fullname: GU JIJIE
– fullname: NAUMOVSKI LOUIE
– fullname: GUPTA SUPRIYA
– fullname: CAO XIANHUA
– fullname: HICKSON JONATHAN A
– fullname: ZAMIRI CAMELLIA
BookMark eNrjYmDJy89L5WRwM1Fw9Avx1A1zdXfTd_HxMVFwCXX0UQhzDPJ0dPJxVXDx93X09FPw9PUN9fN39_F3CvXx9AsG6nFRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGlgYGlmYmppaOxsSpAgBFIC6d
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 항-VEGF/DLL4 이원 가변 도메인 면역글로불린 및 이의 용도
ExternalDocumentID KR20190096459A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20190096459A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:28:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20190096459A3
Notes Application Number: KR20197023545
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190819&DB=EPODOC&CC=KR&NR=20190096459A
ParticipantIDs epo_espacenet_KR20190096459A
PublicationCentury 2000
PublicationDate 20190819
PublicationDateYYYYMMDD 2019-08-19
PublicationDate_xml – month: 08
  year: 2019
  text: 20190819
  day: 19
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies ABBVIE INC
RelatedCompanies_xml – name: ABBVIE INC
Score 3.2004502
Snippet 다가이고 다중 특이적인 결합 단백질, 상기 결합 단백질의 제조 방법, 및 이상 DLL4 및/또는 VEGF 발현 또는 활성을 특징으로 하는, 암, 종양, 및/또는 다른 혈관신생-의존적 질환의 진단, 모니터링, 억제, 예방 및/또는 치료시의 상기 결합 단백질의 용도가 본원에 개시된다....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title 4 ANTI-VEGF/DLL4 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190819&DB=EPODOC&locale=&CC=KR&NR=20190096459A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJo1DdFjR9ommj2thBgHfSBmG3tYLIPsmyEN7LNLjEaIDLj3_c2QXnire2ll-sl99neFeCpKxOW5CnD2CTTVU1P22o_lX21Kzs6e9XzdpKWqQHP10ex9jKjsxp8bGthqj6h31VzRJSoDOW9qPT16j-Jxau3letW-oZLy2c7GnBlEx2jdUMLp3BzICYBDyzFsgbjUPHDXxi66xplxgEclo502WlfTM2yLmW1a1TsMziaIL5FcQ6192UDTqzt32sNOPY2V9443Ejf-gJsjRh-5KhTMbRb3HU1wmPDJVMjdAzTFYQHnuH4xPG82A-GbmDGLsbmuIeTGNUmiUYiFIF9CY-2iKyRigTN_84_H4e71HevoL5YLuQ1kEwmOdVSSjMMemiSMcokRS5nTPZ6UnZuoLkP0-1-8B2cltMygdpmTagXn1_yHi1wkT5UjPsBUuSDhA
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUeMHahPN3hYCWwd9IGZbNzbZB1k2whvZZkmMBojM-O97m6A88db00sv1krvr79q7AjwpImXpPGOITXJNVrWsI_cz0ZcV0dXYqzbvpFmZGvADzUnUlymd1uBjWwtT9Qn9rpojokXlaO9F5a9X_0ksXr2tXLezN5xaPtvxgEsbdIzRDSOcxI2BNQ55aEqmORhFUhD90vC4rlKmH8BhD0Fh2WnfmhhlXcpqN6jYp3A0Rn6L4gxq78smNMzt32tNOPY3V9443Fjf-hxslehB7MoTa2i3ueephCe6RyZ65OqGZxEe-robENf3kyAceqGReIjNcQ0nCbpNEjtWZIX2BTzaVmw6Mgo0-9v_bBTtSq9cQn2xXIgrILlI51TNKM0R9NA0Z5QJilrOmej1hOheQ2sfp5v95AdoOLHvzVDU0S2clKQymdphLagXn1_iDqNxkd1XSvwBnu6Gbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4+ANTI-VEGF%2FDLL4+DUAL+VARIABLE+DOMAIN+IMMUNOGLOBULINS+AND+USES+THEREOF&rft.inventor=HAASCH+DEANNA+L&rft.inventor=LAPPE+SUSAN+E&rft.inventor=CHARI+RAVI&rft.inventor=LI+YINGCHUN&rft.inventor=AMBROSI+DOMINIC+J&rft.inventor=GU+JIJIE&rft.inventor=NAUMOVSKI+LOUIE&rft.inventor=GUPTA+SUPRIYA&rft.inventor=CAO+XIANHUA&rft.inventor=HICKSON+JONATHAN+A&rft.inventor=ZAMIRI+CAMELLIA&rft.date=2019-08-19&rft.externalDBID=A&rft.externalDocID=KR20190096459A